Baytril Tablets - 136 mg

Indicated for the treatment of skin and wound infections, respiratory infections, tonsillitis and urinary tract infections in dogs.

Directions:
Dogs:
Administer orally at a rate to provide 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease and susceptibility of the pathogen. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include inappetance, depression and vomiting.

Cats:
Administer orally at 5 mg/kg (2.27 mg/lb) of body weight. The dose for dogs and cats may be administered either as a single daily dose or divided into 2 equal daily doses administered at 12 hour intervals. The dose should be continued for at least 2 or 3 days beyond cessation of clinical signs, to a maximum of 30 days.

Contraindictions:
The use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). The safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. Consult package insert for details.

Warning:
For use in animals only. In rare instances, use of this product in cats has been associated with retinal toxicity. Do not exceed 5 mg/kg of body weight per day in cats. Safety in breeding or pregnant cats has not been established. Keep out of reach of children. Dispense tablets in tight containers only.

Read package insert carefully for complete details.

View Patient Information Sheet